Zacks Investment Research downgraded Aemetis Inc (NASDAQ:AMTX) to Sell in a report released today.
- Updated: October 12, 2016
Zacks Investment Research has downgraded Aemetis Inc (NASDAQ:AMTX) to Sell in a report released on 10/12/2016.
Yesterday Aemetis Inc (NASDAQ:AMTX) traded -10.34% lower at $1.29. The company’s 50-day moving average is $1.38 and its 200-day moving average is $2.04. The last closing price is down -36.13% from the 200-day moving average, compared to the S&P 500 which has decreased -0.01% over the same time. 63,060 shares of the stock were exchanged, up from an avg. volume of 56,903
With a total market value of $0, Aemetis Inc has with a one year low of $1.01 and a one year high of $3.05 .
Brief Synopsis About Aemetis Inc (NASDAQ:AMTX)
Aemetis, Inc. is an international renewable fuels and biochemicals company. The Company is focused on the production of fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products by conversion of first-generation ethanol and biodiesel plants into biorefineries. Its segments include North America and India. The North America segment includes the Company's approximately 60 million gallon per year capacity ethanol manufacturing plant in Keyes, California and its technology lab in College Park, Maryland. The India segment includes the Company's over 50 million gallon per year capacity biodiesel manufacturing plant in Kakinada, the administrative offices in Hyderabad, India, and the holding companies in Nevada and Mauritius. The Keyes plant produces denatured ethanol, Wet Distillers Grains, corn oil and Condensed Distillers Solubles. It produces biodiesel and refined glycerin at the Kakinada plant.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.